$176 Million is the total value of Exane Asset Management's 12 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 157.1% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
STLA | Sell | STELLANTIS N.V SHSstock | $56,242,361 | +25.6% | 3,101,937 | -1.6% | 32.02% | +11.5% |
GS | New | GOLDMAN SACHS GROUP INC COMstock | $22,566,992 | – | 68,989 | +100.0% | 12.85% | – |
PNC | Sell | PNC FINL SVCS GROUP INC COMstock | $22,022,363 | -25.5% | 173,268 | -7.4% | 12.54% | -33.9% |
New | LINDE PLC SHS ADDEDstock | $17,720,817 | – | 49,856 | +100.0% | 10.09% | – | |
QGEN | New | QIAGEN NV SHS NEWstock | $16,428,893 | – | 361,663 | +100.0% | 9.35% | – |
TMUS | New | T-MOBILE US INC COMstock | $14,823,939 | – | 102,347 | +100.0% | 8.44% | – |
LRCX | New | LAM RESEARCH CORP COMstock | $10,909,339 | – | 20,579 | +100.0% | 6.21% | – |
CHWY | New | CHEWY INC CL Astock | $6,363,758 | – | 170,245 | +100.0% | 3.62% | – |
DECK | Sell | DECKERS OUTDOOR CORP COMstock | $4,994,051 | -24.0% | 11,109 | -32.5% | 2.84% | -32.6% |
UBS | Sell | UBS GROUP AG SHSstock | $3,196,054 | -81.6% | 151,651 | -83.7% | 1.82% | -83.6% |
ALC | New | ALCON AG ORD SHSstock | $250,728 | – | 3,547 | +100.0% | 0.14% | – |
NKE | New | NIKE INC CL Bstock | $141,649 | – | 1,155 | +100.0% | 0.08% | – |
BKNG | Exit | BOOKING HOLDINGS INC COMstock | $0 | – | -5,322 | -100.0% | -6.88% | – |
MSFT | Exit | MICROSOFT CORP COMstock | $0 | – | -73,625 | -100.0% | -11.33% | – |
C | Exit | CITIGROUP INC COM NEWstock | $0 | – | -647,563 | -100.0% | -18.79% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-05-11
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
UBS GROUP AG SHS | 25 | Q1 2023 | 31.8% |
T-MOBILE US INC COM | 25 | Q3 2023 | 23.9% |
GOLDMAN SACHS GROUP INC COM | 16 | Q3 2023 | 14.3% |
BRISTOL-MYERS SQUIBB CO COM | 15 | Q1 2020 | 9.9% |
CITIGROUP INC COM NEW | 15 | Q4 2022 | 18.8% |
GILEAD SCIENCES INC COM | 15 | Q2 2019 | 8.9% |
DBV TECHNOLOGIES S A SPONSORED ADR | 13 | Q2 2019 | 1.7% |
CYTOMX THERAPEUTICS INC COM | 13 | Q4 2020 | 1.3% |
MICROSOFT CORP COM | 12 | Q4 2022 | 19.4% |
TIM PARTICIPACOES S A SPONSORED ADR | 12 | Q3 2019 | 12.2% |
View Exane Asset Management's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-01-24 |
13F-HR | 2023-10-20 |
13F-HR | 2023-07-17 |
13F-HR/A | 2023-05-11 |
13F-HR | 2023-04-25 |
13F-HR | 2023-01-17 |
13F-HR | 2022-10-24 |
13F-HR | 2022-07-15 |
13F-HR | 2022-04-21 |
13F-HR/A | 2022-01-25 |
View Exane Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.